Modulation of cytokine production by a selenoorganic compound (AE-22) in hyperreactive or hyporeactive bronchoalveolar leukocytes of asthmatics or lung cancer patients

Journal of Interferon and Cytokine Research

Volumn 17, Issue 10, 1997, Pages 609-617

  Cembrzyńska Nowak, Monika ^a   Szklarz, Edward ^b   Inglot, Anna D ^a  

^a INSTITUTE OF IMMUNOLOGY AND EXPERIMENTAL THERAPY   (Poland)

^b MILITARY HOSPITAL   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; PHYTOHEMAGGLUTININ; SELENIDE;

ADULT; ARTICLE; ASTHMA; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN REGULATION; FEMALE; FIBEROSCOPE; HUMAN; HUMAN CELL; IMMUNOMODULATION; LUNG CANCER; LUNG LAVAGE; LUNG SMALL CELL CANCER; MALE; PNEUMONIA; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

EID: 0030773050     PISSN: 10799907     EISSN: None     Source Type: Journal    
DOI: 10.1089/jir.1997.17.609     Document Type: Article

References (31)

1. PARNHAM, M.J., and GRAF, E. (1987). Seleno-organic compounds and the therapy of hydroxyperoxide-linked pathological conditions. Biochem. Pharmacol. 36, 3095-3102.
2. SIES, H. (1993). Ebselen, a seleno-organic compound as glutathione peroxidase mimic. Free Radic. Biol. Med. 14, 313-323.
3. ANDERSSON, C.M., HALLBERG, A., LINDEN, M., BRATTSAND, R., MOLDENS, P., and COTGREAVE, I. (1994). Antioxidant activity of some diselenides in biological systems. Free Radic. Biol. Med. 16, 17-28.
4. SHEWE, T. (1995). Molecular action of ebselen - an anti-inflammatory antioxidant. Gen. Pharmacol. 26, 1153-1169.
5. INGLOT, A.D., ZIELINSKA-JENCZYLIK, J., PIASECKI, E., SYPER, L., and MLOCHOWSKI, J. (1990). Organoselenides as potential immunostimulants and inducers of interferon gamma and other cytokines in human peripheral blood leukocytes. Experientia 46, 308-311.
6. INGLOT, A.D., MLOCHOWSKI, J., ZIELIŃSKA-JENCZYLIK, J., PIASECKI, E., and KLOC, K. (1996). Seleno-organic compounds as immunostimulats: an approach to the structure-activity relationship. Arch. Immunol. Ther. Exp. 44, 67-75.
7. CEMBRZYŃSKA-NOWAK, M., and INGLOT, A.D. (1992). Human lymphoid target cells for the cytokine-inducing seleno-organic compounds. Arch. Immunol. Ther. Exp. 40, 235-240.
8. MLOCHOWSKI, J., KLOC, K., SYPER, L., INGLOT, A.D., and PIASECKI, E. (1993). Aromatic and azaaromatic diselenides, benzisoselenazolones and related compounds as immunomodulators active in humans: synthesis and properties. Liebligs Ann. Chem. 1239-1244.
9. CZYRSKI, J.A., and INGLOT, A.D. (1991). Mitogenic activity of selenoorganic compounds in human peripheral blood leukocytes. Experientia 47, 95-97.
10. BLASZCZYK, B., INGLOT, A.D., KOWALCZYK-BRONISZ, S.H., SZYMANIEC, S., and MLOCHOWSKI, J. (1995). Immunotropic activities of benzisoselenazolones and organic diselenides in mice. Arch. Immunol. Ther. Exp. 43, 305-311.
11. WORKSHOP SUMMARY AND GUIDELINES. (1991). Investigative use of bronchoscopy, lavage and bronchial biopsies in asthma and other airway diseases. Clin. Exp. Allergy 21, 533-539.
12. CEMBRZYŃSKA-NOWAK, M., INGLOT, A.D., SZKLARZ, E., and ALBIN, M. (1990). Hyporesponsiveness of human alveolar leukocytes to interferon-alpha and interferon-gamma inducers. Immunobiology 181, 84-96.
13. CEMBRZYŃSKA-NOWAK, M., SZKLARZ, E., INGLOT, A.D., and TEODORCZYK-INJEYAN, J.A. (1993). Elevated release of tumor necrosis factor alpha and interferon-gamma by bronchoalveolar leukocytes from patients with bronchial asthma. Am. Rev. Respir. Dis. 47, 291-295.
14. FLICK, E.D., and GIFFORD, G.E. (1984). Comparison of in vitro cell cytotoxic assays for tumor necrosis factor. J. Immunol. Methods 68, 167-171.
15. HANSEN, M.B., NILSEN, S.E., and BERG, K. (1989). Re-examination and further development of a precise and rapid dye method for measuring cell growth/cell kill. J. Immunol. Methods 119, 203-210.
16. 2-terminal amino acid sequence of a T-cell derived lymphokine with growth factor activity for B-cell hybridomas. Proc. Natl. Acad. Sci. USA 83, 9679-9683.
17. INGLOT, A.D., JANUSZ, M., and LISOWSKI, J. (1996). Colostrinine: a proline-rich polypeptide from ovine colostrum is a modest cytokine inducer in human leukocytes. Arch. Immunol. Ther. Exp. 44, 215-224.
18. LEE, T.H. (1986). Interaction between alveolar macrophages, monocytes and granulocytes: implication for airway inflammation. Ann. Rev. Respir. Dis. 135, 14-17.
19. HUNNINGHAKE, G.W., GADEK, J.E., KAWANAMI, O., FERRANS, V.J., and CRYSTAL, R.G. (1979). Inflammatory and immune processes in the human lung in health and disease: evaluation by bronchoalveolar lavage. Am. J. Pathol. 97, 149-206.
20. STRICKLAND, D., KESS, U.R., and HOLT, P.G. (1996). Regulation of T-cell activation in the lung: alveolar macrophages induce reversible T-cell anergy in vitro associated with inhibition of interleukin-2 receptor signal transduction. Immunology 87, 250-258.
21. BILYK, N., and HOLT, P.G. Cytokine modulation of the immunosuppresive phenotype of pulmonary alveolar macrophage population. Immunology 86, 231-237.
22. LAITINEN, A., and LAITINEN, L.A. (1991). Cellular infiltrates in asthma and in chronic obstructive pulmonary disease. Am. Rev. Respir. Dis. 143, 1159-1160.
23. GOSSET, P., TSICOPOULOS, A., WALLAERT B., VANNIMENUS, C., JOSEPH, M., TONNEL, A.B., and CAPRON, A. (1991). Increased secretion of tumor necrosis factor-α and interleukin-6 by alveolar macrophages consecutive to the development of the late asthmatic reaction. J. Allergy Clin. Immunol. 88, 561-571.
24. BRUNE, B., DIEWALD, B., and ULLRICH, V. (1991). Ebselen affects calcium homeostasis in human platelets. Biochem. Pharmacol. 41, 1805-1811.
25. HATTORI, R., YUI, Y., SHINODA, E., INOUE, R., AOYAMA, T., MASAYASU, KAWAI, C., and SASAYAMA, S. (1996). Effect of ebselen on bovine and rat nitric oxide synthase activity is modified by thiols. Jpn. J. Pharmacol. 72, 191-193.
26. SIBLEY, D.R., and LEFKOWITZ, R.J. (1985). Molecular mechanisms of receptor desensitization using the β-adrenergic receptor-coupled adenylate cyclase system as a model. Nature 317, 124-129.
27. MANNIE, M.D. (1996). The post-activation refractory phase: a mechanism to measure antigenic complexity and ensure self-tolerance among mature peripheral T lymphocytes. Med. Hypotheses 47, 467-470.
28. FISHER, J.R., SCHINDEL, M., STEIN, N., LAHM, H. GALLATI, H., KRAMMER, P.H., and DRINGS, P. (1995). Selective suppression of cytokine secretion in patients with small-cell lung cancer. Ann. Oncol. 6, 921-926.
29. GEORGIADES, J.A., INGLOT, A.D., and GELDER, F. (1996). Tumor markers, alphafetoprotein (AFP), oncofetal protein (OFP), CA-125, CA-50 and CA-19-9 are all cytokine inducers [Abstract]. Eur. Cytokine Netw. 7, 235B.
30. BARNES, P.J., CHUNG, K.F., and PAGE, C.P. (1988). Inflammatory mediators and asthma. Pharmacol. Rev. 49, 48-84.
31. IHDE, D.C., PASS, H.I., and GLATSTEIN, E.J. (1993). Small cell lung cancer. In: Cancer: Principles and Practice of Oncology. V.T. De Vita, Jr., S. Hellman, and S.A. Rosenberg (eds.) Philadelphia: Lippincott, pp. 723-758.